Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Nanjing Vishee Medical Technology Co's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 13.61%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
SHSE:688580's 3-Year ROIIC % is ranked better than 64.78% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 1.47
vs SHSE:688580: 13.61
Nanjing Vishee Medical Technology Co (SHSE:688580) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Nanjing Vishee Medical Technology Co 3-Year ROIIC % Related Terms
Nanjing Vishee Medical Technology Co 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nanjing Vishee Medical Technology Co 3-Year ROIIC % Chart
SHSE:688580 vs ABT, SYK, MDT: 3-Year ROIIC % Comparison
For the Medical Devices subindustry, Nanjing Vishee Medical Technology Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nanjing Vishee Medical Technology Co 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nanjing Vishee Medical Technology Co's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Nanjing Vishee Medical Technology Co's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Nanjing Vishee Medical Technology Co (SHSE:688580) has a 3-Year ROIIC % of 13.61 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Nanjing Vishee Medical Technology Co and its competitors. This is 54% below median its historical median of 29.85. According to the industry distribution chart, Nanjing Vishee Medical Technology Co ranks #280 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 35.2%.
Is Nanjing Vishee Medical Technology Co's 3-Year ROIIC % too high?
Nanjing Vishee Medical Technology Co's current 3-Year ROIIC % of 13.61 is 54% below median its 10-year median of 29.85. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.47. Nanjing Vishee Medical Technology Co's value of 13.61 is 825.9% above this industry median. Based on the distribution chart, Nanjing Vishee Medical Technology Co ranks #280 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Nanjing Vishee Medical Technology Co has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nanjing Vishee Medical Technology Co's 3-Year ROIIC % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nanjing Vishee Medical Technology Co ranks #280 out of 795 companies for 3-Year ROIIC %. This puts Nanjing Vishee Medical Technology Co in the upper half of its industry. The industry median 3-Year ROIIC % is 1.47. Nanjing Vishee Medical Technology Co's value of 13.61 is 825.9% above this benchmark. While the company's 10-year median is 29.85 vs. the industry median of 1.47, Nanjing Vishee Medical Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.47, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nanjing Vishee Medical Technology Co's current 3-Year ROIIC % of 13.61 is 825.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Nanjing Vishee Medical Technology Co and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nanjing Vishee Medical Technology Co's current 3-Year ROIIC % is 13.61, which is 54% below median its own 10-year median of 29.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanjing Vishee Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Nanjing Vishee Medical Technology Co (SHSE:688580) is currently considered Fairly Valued. The stock's GF Value™ is ¥52.73, compared to a current price of ¥49.86 — trading 5.4% below its estimated fair value. The current 3-Year ROIIC % is 13.61, which is 54% below median its 10-year median of 29.85 and 825.9% above the Medical Devices & Instruments industry median of 1.47. Nanjing Vishee Medical Technology Co's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Nanjing Vishee Medical Technology Co (SHSE:688580), the current 3-Year ROIIC % is 13.61 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nanjing Vishee Medical Technology Co (SHSE:688580) Overvalued in 2026?
Based on GuruFocus' analysis, Nanjing Vishee Medical Technology Co stock appears to be undervalued.
The current stock price of ¥49.86 is trading 5.4% below its estimated GF Value™ of ¥52.73.
GuruFocus considers Nanjing Vishee Medical Technology Co to be Fairly Valued.
Key valuation signals for SHSE:688580:
3-Year ROIIC %: 13.61 (54% below median its 10-year median of 29.85)
GF Value™: ¥52.73 vs. price of ¥49.86 (5.4% below fair value)
Industry Position: 825.9% above the Medical Devices & Instruments median (#280 of 795)
No single metric tells the full story. See the SHSE:688580 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nanjing Vishee Medical Technology Co Ltd is engaged in production and sales of rehabilitation medical devices. The company's products under Pelvic floor and postpartum rehabilitation include Pelvic floor electromyography biofeedback instrument; Myotrac series biological stimulation feedback instrument; Ruiyi Series Biostimulation Feedback Apparatus; Magneuro Series Magnetic Stimulator; Female psychological rehabilitation; Neonatal electroencephalograph; Consumables; and under Mental rehabilitation include Multi-parameter biofeedback instrument; Group biofeedback; Magneuro Series Magnetic Stimulator; and Cognitive dysfunction treatment software.
88GF Score
Get the complete analysis for SHSE:688580
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688580 has been successfully added to your 
